SOX1 and endometrial cancer: NR2F1-AS1 targets SOX1 via sponging miR-363 to regulate the progression of endometrial cancer (42) and induces oxaliplatin resistance through miR-363 to target ABCC1 in hepatocellular carcinoma (43).